{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:37:36Z","timestamp":1784389056830,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010447","name":"German Center for Cardiovascular Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003385","name":"Georg-August-Universit\u00e4t G\u00f6ttingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003385","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Maintaining cancer patients\u2019 exercise capacity and therefore patients\u2019 ability to live a self-determined life is of huge importance, but little is known about major determinants. We sought to identify determinants of exercise capacity in patients with a broad spectrum of cancer types, who were already receiving cancer treatment or about to commence such therapy. Exercise capacity was assessed in 253 consecutive patients mostly suffering from advanced cancer using the 6-min walk test (6-MWT). All patients underwent echocardiography, physical examination, resting electrocardiogram, hand grip strength (HGS) measurement, and laboratory assessments. Patients were divided into two groups according to the median distance in the 6-MWT (459\u00a0m). Patients with lower exercise capacity were older, had significantly lower HGS and haemoglobin and higher values of high sensitive (hs) Troponin T and NT-proBNP (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Whilst the co-morbidity burden was significantly higher in this group, no differences were detected for sex, body mass index, tumor type, or cachexia (all <jats:italic>p<\/jats:italic>\u2009&gt;\u20090.2). Using multivariable logistic regression, we found that the presence of anaemia (odds ratio (OR) 6.172, 95% confidence interval (CI) 1.401\u201327.201, <jats:italic>p<\/jats:italic>\u2009=\u20090.016) as well as an increase in hs Troponin T (OR 3.077, 95% CI 1.202\u20135.301, <jats:italic>p<\/jats:italic>\u2009=\u20090.019) remained independent predictors of impaired exercise capacity. Increasing HGS was associated with a reduced risk of a lower exercise capacity (OR 0.896, 95% CI 0.813\u20130.987, <jats:italic>p<\/jats:italic>\u2009=\u20090.026). Screening patients for elevated hs troponin levels as well as reduced HGS may help to identify patients at risk of lower exercise capacity during cancer treatment.<\/jats:p>","DOI":"10.1038\/s41598-023-41390-0","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T16:16:00Z","timestamp":1694189760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictors of lower exercise capacity in patients with cancer"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5904-4652","authenticated-orcid":false,"given":"Ruben","family":"Evertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"G\u00f6dde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Valentova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Garfias-Veitl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias R.","family":"Overbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Braulke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Lena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hadzibegovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalen","family":"Bleckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander O.","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Hasenfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-1125","authenticated-orcid":false,"given":"Andreas","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus S.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"41390_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi, C. & Lippi, G. Current cancer epidemiology. J. Epidemiol. Glob. Health 9, 217\u2013222. https:\/\/doi.org\/10.2991\/jegh.k.191008.001 (2019).","journal-title":"J. Epidemiol. Glob. Health"},{"key":"41390_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrcardio.2010.121","volume":"7","author":"MS Ewer","year":"2010","unstructured":"Ewer, M. S. & Ewer, S. M. Cardiotoxicity of anticancer treatments: What the cardiologist needs to know. Nat. Rev. Cardiol. 7, 564\u2013575. https:\/\/doi.org\/10.1038\/nrcardio.2010.121 (2010).","journal-title":"Nat. Rev. Cardiol."},{"key":"41390_CR3","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/ejhf.1252","volume":"20","author":"MS Anker","year":"2018","unstructured":"Anker, M. S., von Haehling, S., Landmesser, U., Coats, A. J. S. & Anker, S. D. Cancer and heart failure-more than meets the eye: Common risk factors and co-morbidities. Eur. J. Heart Fail. 20, 1382\u20131384. https:\/\/doi.org\/10.1002\/ejhf.1252 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"41390_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ejhf.1165","volume":"20","author":"P Ameri","year":"2018","unstructured":"Ameri, P. et al. Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge. Eur. J. Heart Fail. 20, 879\u2013887. https:\/\/doi.org\/10.1002\/ejhf.1165 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"41390_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"41390_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ejhf.1689","volume":"22","author":"MS Anker","year":"2020","unstructured":"Anker, M. S., Hulsmann, M. & Cleland, J. G. What do patients with heart failure die from? A single assassin or a conspiracy?. Eur. J. Heart Fail. 22, 26\u201328. https:\/\/doi.org\/10.1002\/ejhf.1689 (2020).","journal-title":"Eur. J. Heart Fail."},{"key":"41390_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14175","author":"R Evertz","year":"2022","unstructured":"Evertz, R. et al. Cardiovascular and metabolic determinants of quality of life in patients with cancer. ESC Heart Fail. https:\/\/doi.org\/10.1002\/ehf2.14175 (2022).","journal-title":"ESC Heart Fail."},{"key":"41390_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ctrv.2016.11.010","volume":"52","author":"LM Buffart","year":"2017","unstructured":"Buffart, L. M. et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treat. Rev. 52, 91\u2013104. https:\/\/doi.org\/10.1016\/j.ctrv.2016.11.010 (2017).","journal-title":"Cancer Treat. Rev."},{"key":"41390_CR9","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.jacc.2014.07.948","volume":"64","author":"L Cramer","year":"2014","unstructured":"Cramer, L. et al. Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer. J. Am. Coll. Cardiol. 64, 1310\u20131319. https:\/\/doi.org\/10.1016\/j.jacc.2014.07.948 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"41390_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ejhf.1838","volume":"23","author":"S von Haehling","year":"2021","unstructured":"von Haehling, S. et al. Improving exercise capacity and quality of life using non-invasive heart failure treatments: Evidence from clinical trials. Eur. J. Heart Fail. 23, 92\u2013113. https:\/\/doi.org\/10.1002\/ejhf.1838 (2021).","journal-title":"Eur. J. Heart Fail."},{"key":"41390_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/15412555.2017.1394285","volume":"15","author":"R Marcoa","year":"2018","unstructured":"Marcoa, R. et al. Classification of chronic obstructive pulmonary disease (COPD) according to the new global initiative for chronic obstructive lung disease (GOLD) 2017: Comparison with GOLD 2011. COPD 15, 21\u201326. https:\/\/doi.org\/10.1080\/15412555.2017.1394285 (2018).","journal-title":"COPD"},{"key":"41390_CR12","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1714\/3026.30245","volume":"19","author":"B Williams","year":"2018","unstructured":"Williams, B. et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Ital. Cardiol. (Rome) 19, 3S-73S. https:\/\/doi.org\/10.1714\/3026.30245 (2018).","journal-title":"Ital. Cardiol. (Rome)"},{"key":"41390_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 166, 111\u2013117. https:\/\/doi.org\/10.1164\/ajrccm.166.1.at1102 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"41390_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1200\/JCO.19.01661","volume":"38","author":"KK Ness","year":"2020","unstructured":"Ness, K. K. et al. Exercise intolerance, mortality, and organ system impairment in adult survivors of childhood cancer. J. Clin. Oncol. 38, 29\u201342. https:\/\/doi.org\/10.1200\/JCO.19.01661 (2020).","journal-title":"J. Clin. Oncol."},{"key":"41390_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/epirev\/mxx007","volume":"39","author":"P Cormie","year":"2017","unstructured":"Cormie, P., Zopf, E. M., Zhang, X. & Schmitz, K. H. The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects. Epidemiol. Rev. 39, 71\u201392. https:\/\/doi.org\/10.1093\/epirev\/mxx007 (2017).","journal-title":"Epidemiol. Rev."},{"key":"41390_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/ecc.12201","volume":"23","author":"W Banzer","year":"2014","unstructured":"Banzer, W. et al. Changes in exercise capacity, quality of life and fatigue in cancer patients during an intervention. Eur. J. Cancer Care (Engl.) 23, 624\u2013629. https:\/\/doi.org\/10.1111\/ecc.12201 (2014).","journal-title":"Eur. J. Cancer Care (Engl.)"},{"key":"41390_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/pbc.24410","volume":"60","author":"AM Miller","year":"2013","unstructured":"Miller, A. M. et al. Exercise capacity in long-term survivors of pediatric cancer: An analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study. Pediatr. Blood Cancer 60, 663\u2013668. https:\/\/doi.org\/10.1002\/pbc.24410 (2013).","journal-title":"Pediatr. Blood Cancer"},{"key":"41390_CR18","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.jacc.2012.08.1006","volume":"60","author":"CR deFilippi","year":"2012","unstructured":"deFilippi, C. R. et al. Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults. J. Am. Coll. Cardiol. 60, 2539\u20132547. https:\/\/doi.org\/10.1016\/j.jacc.2012.08.1006 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"41390_CR19","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.jacc.2012.12.048","volume":"61","author":"KM Eggers","year":"2013","unstructured":"Eggers, K. M., Venge, P., Lindahl, B. & Lind, L. Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. J. Am. Coll. Cardiol. 61, 1906\u20131913. https:\/\/doi.org\/10.1016\/j.jacc.2012.12.048 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"41390_CR20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01314-2019","author":"B Waschki","year":"2020","unstructured":"Waschki, B. et al. High-sensitivity troponin I and all-cause mortality in patients with stable COPD: An analysis of the COSYCONET study. Eur. Respir. J. https:\/\/doi.org\/10.1183\/13993003.01314-2019 (2020).","journal-title":"Eur. Respir. J."},{"key":"41390_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5603\/CJ.a2020.0089","volume":"27","author":"A Lorente-Ros","year":"2020","unstructured":"Lorente-Ros, A. et al. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients. Cardiol. J. 27, 489\u2013496. https:\/\/doi.org\/10.5603\/CJ.a2020.0089 (2020).","journal-title":"Cardiol. J."},{"key":"41390_CR22","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1161\/01.cir.102.16.1964","volume":"102","author":"J Dierkes","year":"2000","unstructured":"Dierkes, J. et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 102, 1964\u20131969. https:\/\/doi.org\/10.1161\/01.cir.102.16.1964 (2000).","journal-title":"Circulation"},{"key":"41390_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ahj.2003.10.014","volume":"147","author":"MP Hudson","year":"2004","unstructured":"Hudson, M. P. et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: A prospective analysis. Am. Heart J. 147, 546\u2013552. https:\/\/doi.org\/10.1016\/j.ahj.2003.10.014 (2004).","journal-title":"Am. Heart J."},{"key":"41390_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1515\/dx-2019-0061","volume":"8","author":"G Lippi","year":"2021","unstructured":"Lippi, G., Cervellin, G. & Sanchis-Gomar, F. Predicting mortality with cardiac troponins: Recent insights from meta-analyses. Diagnosis (Berl) 8, 37\u201349. https:\/\/doi.org\/10.1515\/dx-2019-0061 (2021).","journal-title":"Diagnosis (Berl)"},{"key":"41390_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244","author":"AR Lyon","year":"2022","unstructured":"Lyon, A. R. et al. ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehac244 (2022).","journal-title":"Eur. Heart J."},{"key":"41390_CR26","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","volume":"109","author":"D Cardinale","year":"2004","unstructured":"Cardinale, D. et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation 109, 2749\u20132754. https:\/\/doi.org\/10.1161\/01.CIR.0000130926.51766.CC (2004).","journal-title":"Circulation"},{"key":"41390_CR27","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"AR Lyon","year":"2020","unstructured":"Lyon, A. R. et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: A position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. Eur. J. Heart Fail. 22, 1945\u20131960. https:\/\/doi.org\/10.1002\/ejhf.1920 (2020).","journal-title":"Eur. J. Heart Fail."},{"key":"41390_CR28","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","volume":"40","author":"H Ludwig","year":"2004","unstructured":"Ludwig, H. et al. The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur. J. Cancer 40, 2293\u20132306. https:\/\/doi.org\/10.1016\/j.ejca.2004.06.019 (2004).","journal-title":"Eur. J. Cancer"},{"key":"41390_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/00007256-200939050-00005","volume":"39","author":"W Ament","year":"2009","unstructured":"Ament, W. & Verkerke, G. J. Exercise and fatigue. Sports Med. 39, 389\u2013422. https:\/\/doi.org\/10.2165\/00007256-200939050-00005 (2009).","journal-title":"Sports Med."},{"key":"41390_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/cs0760265","volume":"76","author":"G Mayer","year":"1989","unstructured":"Mayer, G., Thum, J. & Graf, H. Anaemia and reduced exercise capacity in patients on chronic haemodialysis. Clin. Sci. (Lond.) 76, 265\u2013268. https:\/\/doi.org\/10.1042\/cs0760265 (1989).","journal-title":"Clin. Sci. (Lond.)"},{"key":"41390_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijcard.2015.11.178","volume":"205","author":"N Ebner","year":"2016","unstructured":"Ebner, N. et al. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the studies investigating co-morbidities aggravating heart failure. Int. J. Cardiol. 205, 6\u201312. https:\/\/doi.org\/10.1016\/j.ijcard.2015.11.178 (2016).","journal-title":"Int. J. Cardiol."},{"key":"41390_CR32","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1513\/AnnalsATS.201610-803FR","volume":"14","author":"MF Piepoli","year":"2017","unstructured":"Piepoli, M. F., Corra, U. & Agostoni, P. Cardiopulmonary exercise testing in patients with heart failure with specific comorbidities. Ann. Am. Thorac. Soc. 14, S110\u2013S115. https:\/\/doi.org\/10.1513\/AnnalsATS.201610-803FR (2017).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"41390_CR33","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/s0002-9149(03)00030-4","volume":"91","author":"PR Kalra","year":"2003","unstructured":"Kalra, P. R. et al. Effect of anemia on exercise tolerance in chronic heart failure in men. Am. J. Cardiol. 91, 888\u2013891. https:\/\/doi.org\/10.1016\/s0002-9149(03)00030-4 (2003).","journal-title":"Am. J. Cardiol."},{"key":"41390_CR34","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/cncr.22267","volume":"107","author":"JS Drouin","year":"2006","unstructured":"Drouin, J. S. et al. Random control clinical trial on the effects of aerobic exercise training on erythrocyte levels during radiation treatment for breast cancer. Cancer 107, 2490\u20132495. https:\/\/doi.org\/10.1002\/cncr.22267 (2006).","journal-title":"Cancer"},{"key":"41390_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000335620","volume":"127","author":"M Hu","year":"2012","unstructured":"Hu, M. & Lin, W. Effects of exercise training on red blood cell production: Implications for anemia. Acta Haematol. 127, 156\u2013164. https:\/\/doi.org\/10.1159\/000335620 (2012).","journal-title":"Acta Haematol."},{"key":"41390_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/s0167-5273(02)00574-0","volume":"90","author":"J Szachniewicz","year":"2003","unstructured":"Szachniewicz, J. et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int. J. Cardiol. 90, 303\u2013308. https:\/\/doi.org\/10.1016\/s0167-5273(02)00574-0 (2003).","journal-title":"Int. J. Cardiol."},{"key":"41390_CR37","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker, S. D. et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med. 361, 2436\u20132448. https:\/\/doi.org\/10.1056\/NEJMoa0908355 (2009).","journal-title":"N. Engl. J. Med."},{"key":"41390_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski, P. et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger. Eur. Heart J. 36, 657\u2013668. https:\/\/doi.org\/10.1093\/eurheartj\/ehu385 (2015).","journal-title":"Eur. Heart J."},{"key":"41390_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.resinv.2019.03.014","volume":"57","author":"Y Kyomoto","year":"2019","unstructured":"Kyomoto, Y. et al. Handgrip strength measurement in patients with chronic obstructive pulmonary disease: Possible predictor of exercise capacity. Respir. Investig. 57, 499\u2013505. https:\/\/doi.org\/10.1016\/j.resinv.2019.03.014 (2019).","journal-title":"Respir. Investig."},{"key":"41390_CR40","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1097\/HCR.0000000000000458","volume":"40","author":"W Kim","year":"2020","unstructured":"Kim, W. et al. Handgrip strength as a predictor of exercise capacity in coronary heart disease. J. Cardiopulm Rehabil. Prev. 40, E10\u2013E13. https:\/\/doi.org\/10.1097\/HCR.0000000000000458 (2020).","journal-title":"J. Cardiopulm Rehabil. Prev."},{"key":"41390_CR41","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.nut.2009.06.015","volume":"26","author":"LH Jakobsen","year":"2010","unstructured":"Jakobsen, L. H., Rask, I. K. & Kondrup, J. Validation of handgrip strength and endurance as a measure of physical function and quality of life in healthy subjects and patients. Nutrition 26, 542\u2013550. https:\/\/doi.org\/10.1016\/j.nut.2009.06.015 (2010).","journal-title":"Nutrition"},{"key":"41390_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4082\/kjfm.20.0060","volume":"42","author":"H Kim","year":"2021","unstructured":"Kim, H., Yoo, S., Kim, H., Park, S. G. & Son, M. Cancer survivors with low hand grip strength have decreased quality of life compared with healthy controls: The Korea National Health and Nutrition Examination Survey 2014\u20132017. Korean J. Fam. Med. 42, 204\u2013211. https:\/\/doi.org\/10.4082\/kjfm.20.0060 (2021).","journal-title":"Korean J. Fam. Med."},{"key":"41390_CR43","doi-asserted-by":"publisher","first-page":"e030938","DOI":"10.1136\/bmjopen-2019-030938","volume":"9","author":"J Paek","year":"2019","unstructured":"Paek, J. & Choi, Y. J. Association between hand grip strength and impaired health-related quality of life in Korean cancer survivors: A cross-sectional study. BMJ Open 9, e030938. https:\/\/doi.org\/10.1136\/bmjopen-2019-030938 (2019).","journal-title":"BMJ Open"},{"key":"41390_CR44","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/jcsm.12614","volume":"11","author":"CL Zhuang","year":"2020","unstructured":"Zhuang, C. L. et al. Associations of low handgrip strength with cancer mortality: A multicentre observational study. J. Cachexia Sarcopenia Muscle 11, 1476\u20131486. https:\/\/doi.org\/10.1002\/jcsm.12614 (2020).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"41390_CR45","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1007\/s00520-013-1894-4","volume":"21","author":"RD Kilgour","year":"2013","unstructured":"Kilgour, R. D. et al. Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer 21, 3261\u20133270. https:\/\/doi.org\/10.1007\/s00520-013-1894-4 (2013).","journal-title":"Support Care Cancer"},{"key":"41390_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13248","author":"S Hadzibegovic","year":"2023","unstructured":"Hadzibegovic, S. et al. Hand grip strength in patients with advanced cancer: A prospective study. J. Cachexia Sarcopenia Muscle https:\/\/doi.org\/10.1002\/jcsm.13248 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41390-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41390-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41390-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T01:09:13Z","timestamp":1700442553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41390-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41390"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-41390-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"assertion":[{"value":"23 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MSA reports personal fees from Servier, outside the submitted work. All authors declare no conflict of interest with respect to this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14861"}}